Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-15), Zosano Pharma's Beta is Not available.
Zosano Pharma Beta Historical Data
The historical data trend for Zosano Pharma's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zosano Pharma's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zosano Pharma's Beta Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zosano Pharma's Beta distribution charts can be found below:
* The bar in red indicates where Zosano Pharma's Beta falls into.
Zosano Pharma Beta Calculation
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Zosano Pharma (OTCPK:ZSANQ) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Zosano Pharma Beta Related Terms
Thank you for viewing the detailed overview of Zosano Pharma's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.
Zosano Pharma (Zosano Pharma) Business Description
Zosano Pharma Corp is a clinical-stage biopharmaceutical company. It is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using the proprietary transdermal microneedle system. The system is designed to facilitate rapid drug absorption into the bloodstream, which can result in an improved pharmacokinetic profile compared to original dosage forms. The company's operating segment is to develop human pharmaceutical products. Its primary product candidate is Qtrypta (M207) which is the proprietary formulation of zolmitriptan delivered utilizing the system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZSANQ has been successfully added to your 